A Novel Mutation of the CYP11B2 in a Saudi Infant with Primary Hypoaldosteronism

Lama Alfaraidi1, Abrar Alfaifi1, Rawan Alquaiz1

  • 1College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Insights

A rare genetic disorder, isolated hypoaldosteronism, causes severe salt loss in infants. Researchers identified a novel mutation in the CYP11B2 gene responsible for this aldosterone synthase deficiency.

Area of Science:

  • Endocrinology
  • Genetics
  • Pediatrics

Background:

  • Isolated hypoaldosteronism is a rare autosomal recessive disorder.
  • It presents in infancy with severe salt wasting and failure to thrive.
  • Consanguinity is a risk factor in affected populations.

Observation:

  • A 6-month-old Saudi infant exhibited failure to thrive and developmental delay.
  • Laboratory findings included hyponatremia, hyperkalemia, metabolic acidosis, high renin, and low aldosterone.
  • Genetic analysis revealed a novel homozygous mutation (c.1398+T>A) in the CYP11B2 gene.

Findings:

  • The identified T to A transition at position 1398 + 2 in exon 8 of CYP11B2 is a novel homozygous mutation.
  • Bioinformatic predictions suggest this mutation is pathogenic, leading to aldosterone synthase deficiency.
  • This genetic finding explains the clinical presentation of salt-wasting in the infant.

Implications:

  • This discovery expands the known genetic causes of isolated hypoaldosteronism.
  • Early diagnosis and adequate replacement treatment are crucial for a good long-term prognosis.
  • Further research into aldosterone synthase deficiency can improve patient outcomes.

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.4K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.4K
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
14
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
18
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.3K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
898